künstliche intelligenz

We cordially invite you to join the next ASL Network Dinner which will take place as usually in conjunction with ISMRM – this time in Singapore. mediri and Gold Standard Phantoms are looking forward to be your host on the evening of Sunday, May 5th in the Neon Pidgeon.

Meet leading experts as well as interested newbies in the research field of Arterial Spin Labelling and enjoy free drinks and food. See you there!
Don’t forget to register here.

We proudly announce that mediri has once again received the Digital Innovator 2024 award from CHIP in the category ”medical technology“.
In times of digitization, CHIP and data analysis specialist Globis Consulting have studied the innovative power of German companies and institutes in digitization. CHIP is known as one of the top recommended brands. See the full ranking here.

Recently, a newspaper article about our project with bosomshield got mentioned in the newspaper echo-online. If you want to know more about the importance of our work and how we want to improve the field of breast cancer, you can read the article down below. 

a newspaper article scan

Today is International Day of Radiology to promote the seismic impact of radiology on medicine – earlier detection, fewer surgeries, and game-changing treatment outcomes. Analyzing radiological images in multi centric clinical studies can be challenging considering standardization and patient data privacy.
Mediri is constantly evolving its image data management platform mTRIAL for secure and reliable central reads in clinical studies. Currently, mTRIAL is getting ready for RANO 2.0 evaluation of low- and high-grade gliomas according to the recently published update by Wen et al. Stay posted.

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults | Journal of Clinical Oncology (ascopubs.org)

New office. New Neighbours. New view.
It’s done! We have offically moved to Am Taubenfeld 21/1 in 69123 Heidelberg.

Klinische Forschung neu denken: Vom Patienten bis zur KI.

Thank you for having us at the BosomShield kick off meeting. BosomShield is a project aiming a computer-aided design system for breast cancer classification and prognosis of relapse.
If you want to know further information about this project, visit bosomshield.eu.

We proudly announce that the ASPIRE team has a new member: Darmstadt University of Applied Sciences joins the consortium and brings in expertise for AI-based brain image analysis and atlas creation. Together we will establish a platform independent dementia diagnosis support based on arterial spin labeling images.

You want the brain MRIs of your MS patients to be evaluated by the SPM Lesion Segmentation Tool but without installing and adapting any software packages? Or do you need consistent evaluations across multiple centres of a clinical trial? mTRIAL offers Lesion analysis of FLAIR images based on the SPM LST algorithm and produces clear reports. You only need to upload your image data to the mTRIAL platform, pseudonymization is performed on the fly, evaluation and reporting can be done within minutes.
Interested? Don’t hesitate to contact us.

30 years after the first successful Arterial Spin Labeling (ASL) MR image acquisition to measure cerebral blood flow in rat brain, the early detection of Alzheimer’s using ASL gains enormous importance with the recent publication of the study results for Lecanemab. Now that there is hope for efficient therapies in dementia diseases, it is a good time to review the steps that have been gone since then. Many initiatives aiming at reliable and comparable quantification of brain perfusion measurements are paving the way for broad usage of ASL in clinical studies focusing on Alzheimer‘s and other dementia diseases.